Examples of 'myelosuppression' in a sentence
Meaning of "myelosuppression"
Myelosuppression (noun) - Myelosuppression is a condition characterized by a decrease in the production of blood cells by the bone marrow, often as a side effect of certain medications or treatments
Show more definitions
- A reduction of bone marrow activity that leads to a lower concentration of platelets, red blood cells and white blood cells
How to use "myelosuppression" in a sentence
Basic
Advanced
myelosuppression
Complications of myelosuppression include infections and bleeding.
The most significant adverse event was myelosuppression.
Myelosuppression was commonly reported in all patient populations.
The main toxicity in all experiments was myelosuppression.
Myelosuppression was mostly mild or moderate and manageable.
The cause of myelosuppression is not clear.
Myelosuppression was the primary reason for discontinuation.
Chronic overdosage may give rise to serious myelosuppression.
Myelosuppression was dose related and dose limiting.
Severe renal or hepatic failure and severe myelosuppression.
Management of myelosuppression and associated complications.
All patients experienced a profound myelosuppression.
Mitoxantrone causes myelosuppression as an extension of its pharmacological action.
Infections and malignancies causing myelosuppression.
Fatal myelosuppression has been reported following etoposide administration.
See also
Mitoxantrone administered at any dose can cause myelosuppression.
Myelosuppression is the most common side effect of etoposide.
The main symptom of intoxication is myelosuppression.
Myelosuppression is the dose limiting side effect of vinblastine.
Advise patients of the risks of myelosuppression.
Severe myelosuppression is usually dose limiting.
No evidence of cumulative myelosuppression was observed.
Myelosuppression and neuropathy have resolved.
Pulmonary embolism or severe myelosuppression.
Severe myelosuppression may occur.
Most patients continued treatment without further evidence of myelosuppression.
Recovery from myelosuppression is usually rapid when therapy is discontinued.
Basiliximab does not cause myelosuppression.
Myelosuppression may lead to neutropenia and an increased risk of infection.
Patients are not allowed to receive growth factors for myelosuppression.
Severe myelosuppression with resulting infection or haemorrhage may occur.
It is important to recognize that this treatment results in prolonged myelosuppression.
Myelosuppression and neutropenia are the major toxicities that are developed.
There are different types of myelosuppression depending on which blood cell is affected.
Myelosuppression is thus common.
Depending on the degree of myelosuppression there can be an increased risk of infection.
Myelosuppression was generally.
He said current methods of managing myelosuppression were costly and of limited effectiveness.
Myelosuppression and immunosuppression.
Haematopoietic growth factor has been used in patients with resistant myelosuppression.
An increased risk of myelosuppression and infection was also observed in paediatric patients.
Haematopoetic growth factor has been used in patients with resistant myelosuppression.
The recovery from myelosuppression is rapid when hydroxycarbamide therapy is interrupted.
Increases in dose to be continued until mild myelosuppression absolute neutrophil count.
Myelosuppression is the most common dose limiting side effect of teniposide.
The main severe toxicities of irinotecan are delayed diarrhea and myelosuppression.
Myelosuppression is the most common dose limiting side effect of vinorelbine.
The haematopoietic system was the primary target organ of toxicity showing myelosuppression.
Myelosuppression is the most common dose limiting side effect of daunorubicin.
The most serious side effects with mitoxantrone are myocardial toxicity and myelosuppression.
